Synthesis and Evaluation of Hydrophilic Linkers for Antibody-Maytansinoid Conjugates

被引:147
|
作者
Zhao, Robert Y. [1 ]
Wilhelm, Sharon D. [1 ]
Audette, Charlene [1 ]
Jones, Gregory [1 ]
Leece, Barbara A. [1 ]
Lazar, Alexandru C. [1 ]
Goldmacher, Victor S. [1 ]
Singh, Rajeeva [1 ]
Kovtun, Yelena [1 ]
Widdison, Wayne C. [1 ]
Lambert, John M. [1 ]
Chari, Ravi V. J. [1 ]
机构
[1] ImmunoGen Inc, Waltham, MA 02451 USA
关键词
CALICHEAMICIN CONJUGATE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CANCER; CELLS; DOXORUBICIN; ACID; TRANSPORTERS; CHEMOTHERAPY; SPECIFICITY;
D O I
10.1021/jm2002958
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are described. These linkers contain either a negatively charged sulfonate group or a hydrophilic, noncharged PEG group in addition to an amine-reactive N-hydroxysuccinimide (NHS) ester and sulfhydryl reactive termini. These hydrophilic linkers enable conjugation of hydrophobic organic molecule drugs, such as a maytansinoid, at a higher drug/antibody ratio (DAR) than hydrophobic SPDB and SMCC linkers used earlier without triggering aggregation or loss of affinity of the resulting conjugate. Antibody maytansinoid conjugates (AMCs) bearing these sulfonate- or PEG-containing hydrophilic linkers were, depending on the nature of the targeted cells, equally to more cytotoxic to antigen-positive cells and equally to less cytotoxic to antigen-negative cells than conjugates made with SPDB or SMCC linkers and thus typically displayed a wider selectivity window, particularly against multidrug resistant (MDR) cancer cell lines in vitro and tumor xenograft models in vivo.
引用
收藏
页码:3606 / 3623
页数:18
相关论文
共 50 条
  • [31] Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates
    Marvin, Christopher C.
    Hobson, Adrian D.
    Mcpherson, Michael
    Dunstan, Theresa A.
    Vargo, Thomas R.
    Hayes, Martin E.
    Fettis, Margaret M.
    Bischoff, Agnieszka
    Wang, Lu
    Wang, Lu
    Hernandez Jr, Axel
    Jia, Ying
    Oh, Jason Z.
    Tian, Yu
    BIOCONJUGATE CHEMISTRY, 2023, 34 (10) : 1835 - 1850
  • [32] Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency
    Anami, Yasuaki
    Xiong, Wei
    Gui, Xun
    Deng, Mi
    Zhang, Cheng Cheng
    Zhang, Ningyan
    An, Zhiqiang
    Tsuchikama, Kyoji
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2017, 15 (26) : 5635 - 5642
  • [33] Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugates
    Poudel, Yam B.
    Rao, Chetana
    Kotapati, Srikanth
    Deshpande, Madhura
    Thevanayagam, Lourdes
    Pan, Chin
    Cardarelli, Josephine
    Chowdari, Naidu
    Kaspady, Mahammed
    Samikannu, Ramesh
    Kuppusamy, Prakasam
    Saravanakumar, Pon
    Arunachalam, Pirama N.
    Deshpande, Shrikant
    Rangan, Vangipuram
    Rampulla, Richard
    Mathur, Arvind
    Vite, Gregory D.
    Gangwar, Sanjeev
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
  • [34] Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers
    Gregson, Stephen J.
    Barrett, Allison M.
    Patel, Neki V.
    Kang, Gyoung-Dong
    Schiavone, Davide
    Sult, Erin
    Barry, Conor S.
    Vijayakrishnan, Balakumar
    Adams, Lauren R.
    Masterson, Luke A.
    D'Hooge, Francois
    Snaith, Mike
    Harper, Jay
    Hartley, John A.
    Howard, Philip W.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 591 - 607
  • [35] Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives
    Zhang, Yifan
    Ding, Mengyuan
    Wang, Lei
    Yin, Sicheng
    Zhang, Liang
    Cao, Xuemei
    Chen, Zhiyang
    Li, Weinan
    Guo, Qingsong
    Zhu, Shulei
    Lu, Wei
    Yang, Tong
    PLOS ONE, 2023, 18 (12):
  • [36] Design, Synthesis, and Biological Evaluation of Antibody-Drug Conjugates Comprised of Potent Camptothecin Analogues
    Burke, Patrick J.
    Senter, Peter D.
    Meyer, David W.
    Miyamoto, Jamie B.
    Anderson, Martha
    Toki, Brian E.
    Manikumar, Govindarajan
    Wani, Mansukh C.
    Kroll, David J.
    Jeffrey, Scott C.
    BIOCONJUGATE CHEMISTRY, 2009, 20 (06) : 1242 - 1250
  • [37] Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment-Drug Conjugates
    Kim, Eunhee G.
    Jeong, Jieun
    Lee, Junghyeon
    Jung, Hyeryeon
    Kim, Minho
    Zhao, Yi
    Yi, Eugene C.
    Kim, Kristine M.
    BIOMOLECULES, 2020, 10 (06) : 1 - 22
  • [38] Hydrophilic Monomethyl Auristatin E Derivatives as Novel Candidates for the Design of Antibody-Drug Conjugates
    Ekholm, Filip S.
    Ruokonen, Suvi-Katriina
    Redon, Marina
    Pitkanen, Virve
    Vilkman, Anja
    Saarinen, Juhani
    Helin, Jari
    Satomaa, Tero
    Wiedmer, Susanne K.
    SEPARATIONS, 2018, 6 (01)
  • [39] Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs)
    Reid, Emily E.
    Archer, Katie E.
    Shizuka, Manami
    McShea, Molly A.
    Maloney, Erin K.
    Ab, Olga
    Lanieri, Leanne
    Wilhelm, Alan
    Ponte, Jose F.
    Yoder, Nicholas C.
    Chari, Ravi V. J.
    Miller, Michael L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (17) : 2455 - 2458
  • [40] Evaluation of PNU-159682 antibody drug conjugates (ADCs)
    Holte, Dane
    Lyssikatos, Joseph P.
    Valdiosera, Amanda M.
    Swinney, Zachary
    Sisodiya, Vikram
    Sandoval, Joseph
    Lee, Christina
    Aujay, Monette A.
    Tchelepi, Robert B.
    Hamdy, Omar M.
    Gu, Christine
    Lin, Baiwei
    Sarvaiya, Hetal
    Pysz, Marybeth A.
    Laysang, Amy
    Williams, Samuel
    Lee, Dong Jun
    Holda, Magda K.
    Purcell, James W.
    Gavrilyuk, Julia
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (24)